Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00540371
Other study ID # 19992154
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 1999
Est. completion date February 2009

Study information

Verified date October 2022
Source University of California, Irvine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of the study is to improve the efficacy of pulsed dye laser treatment of port wine stain birthmarks. Involvement in the protocol will involve formal documentation of the level of treatment pain, duration of post-treatment purpura and incidence of side effects. In addition, measurements will be taken of blood substances that promote blood vessel formation/regrowth and non-invasive reflectance measurements and photographs will be taken before and after treatment. The objective of this study is to document the degree of port wine stain lightening, the incidence of side effects and the presence of angiogenic factors induced during treatment with the pulsed dye laser in association with cooling agent. This information ultimately lead to improved treatment.


Description:

The flashlamp-pumped pulsed dye laser has offered the best results with the lowest incidence of side effects. The yellow light is preferentially absorbed by hemoglobin allowing more selective destruction of the ectatic capillaries in the dermis. The flashlamp-pumped pulsed dye laser has become the treatment of choice for port wine stain birthmarks; however, therapeutic challenges remain. The epidermis is not totally spared due to partial absorption of energy therein by melanin which presents an optical barrier through which the light must pass to reach the underlying blood vessels. Absorption of laser energy by melanin causes localized heating in the epidermis, which may, if not controlled, produce permanent complications such as hypertrophic scarring or dyspigmentation. Clinical studies have demonstrated the efficacy and safety of cryogen spray cooling during pulsed laser treatment of port wine stain birthmarks. This technology allows the use of higher incident laser light dosages and has been demonstrated to improve treatment results. cryogen spray cooling also decreases treatment pain and the duration of post-laser treatment purpura.


Recruitment information / eligibility

Status Completed
Enrollment 136
Est. completion date February 2009
Est. primary completion date February 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Month to 75 Years
Eligibility Inclusion Criteria: - Diagnosis of PWS birthmark or age and sex matched control of a subject with a PWS birthmark - Apparent good health as documented by medical history and physical examination - Ability to understand and carry out subject instructions Exclusion Criteria: - Pregnancy - History of cutaneous photosensitivity - History of photodermatoses, skin cancer or other cancer - Any therapy to the proposed treatment sites within the previous two months - Current participation in any other investigational drug evaluation - Concurrent use of known photosensitizing drugs - Inability to understand and carry out subject instructions

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Port wine stain Birthmark
Port wine stain Birthmark

Locations

Country Name City State
United States Beckman Lase Institute Medical Clinic Unversity of California Irvine Irvine California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Irvine Beckman Laser Institute University of California Irvine

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Withdrawn NCT01438047 - Optical Frequency Domain Imaging (OFDI) in Dermatology N/A
Terminated NCT00782483 - Personalized Interactive Laser Therapy of Port Wine Stain N/A
Completed NCT03948997 - The Role of Angiogenesis-related Pathways in the Development of Port Wine Stains N/A
Completed NCT01364857 - French National Cohort of Children With Port Wine Stain N/A
Withdrawn NCT00969397 - Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks Phase 1/Phase 2
Completed NCT00800722 - A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks. Phase 1
Completed NCT00585247 - Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks N/A
Active, not recruiting NCT00247299 - Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform N/A
Completed NCT00580736 - Optical Clearing of the Skin in Conjunction With Laser Treatments Phase 1
Completed NCT00540566 - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Withdrawn NCT02035319 - Effect of Laser Treatment on Capillary Malformations N/A
Withdrawn NCT01166919 - Pilot Study on the Use of the Matrix Radiofrequencyfor Treatment of Port Wine Stain Birthmarks Phase 1
Completed NCT00830466 - A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks. Phase 1
Completed NCT01333553 - Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
Withdrawn NCT00580944 - Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks Phase 1